logo
    Return of the Coronavirus: 2019-nCoV
    1,377
    Citation
    32
    Reference
    10
    Related Paper
    Citation Trend
    Abstract:
    The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
    Keywords:
    Coronavirus
    2019-20 coronavirus outbreak
    Betacoronavirus
    Coronavirus Infections
    Pandemic
    Coronavirus
    Betacoronavirus
    2019-20 coronavirus outbreak
    Common cold
    Coronavirus Infections
    Coronaviridae
    Pandemic
    Citations (0)
    2019-20 coronavirus outbreak
    Betacoronavirus
    Coronavirus
    Coronavirus Infections
    Pandemic
    Sars virus
    Viral therapy
    Citations (0)
    Children have a right to be heard. Involving children in decision-making and development promotes their rights which can make a positive difference locally and globally on issues that matter to them.1 The United Nations Convention on the Rights of the Child (UNCRC) defines a child as anyone who has not yet reached their 18th birthday. The UNCRC includes obligations of communities and states to fulfil children’s rights2 and includes respect for the views of the child (Article 12) and freedom of expression (Article 13). While seeking children’s views in a tokenistic fashion is wrong, not seeking their input on the basis that it would be tokenistic is also wrong, but arguably not as wrong as not seeking their views at all.3 So, what about …
    Pandemic
    2019-20 coronavirus outbreak
    Coronavirus
    The recent pandemic caused by the novel human coronavirus, referrred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), not only is having a great impact on the health care systems and economies in all continents but it is also causing radical changes of common habits and life styles. The novel coronavirus (CoV) recognises, with high probability, a zoonotic origin but the role of animals in the SARS-CoV-2 epidemiology is still largely unknown. However, CoVs have been known in animals since several decades, so that veterinary coronavirologists have a great expertise on how to face CoV infections in animals, which could represent a model for SARS-CoV-2 infection in humans. In the present paper, we provide an up-to-date review of the literature currently available on animal CoVs, focusing on the molecular mechanisms that are responsible for the emergence of novel CoV strains with different antigenic, biologic and/or pathogenetic features. A full comprehension of the mechanisms driving the evolution of animal CoVs will help better understand the emergence, spreading, and evolution of SARS-CoV-2.
    Coronavirus
    Pandemic
    Betacoronavirus
    2019-20 coronavirus outbreak
    Coronavirus Infections
    Citations (380)
    ABSTRACT We discovered a novel Betacoronavirus lineage A coronavirus, China Rattus coronavirus (ChRCoV) HKU24, from Norway rats in China. ChRCoV HKU24 occupied a deep branch at the root of members of Betacoronavirus 1 , being distinct from murine coronavirus and human coronavirus HKU1. Its unique putative cleavage sites between nonstructural proteins 1 and 2 and in the spike (S) protein and low sequence identities to other lineage A betacoronaviruses (βCoVs) in conserved replicase domains support ChRCoV HKU24 as a separate species. ChRCoV HKU24 possessed genome features that resemble those of both Betacoronavirus 1 and murine coronavirus, being closer to Betacoronavirus 1 in most predicted proteins but closer to murine coronavirus by G+C content, the presence of a single nonstructural protein (NS4), and an absent transcription regulatory sequence for the envelope (E) protein. Its N-terminal domain (NTD) demonstrated higher sequence identity to the bovine coronavirus (BCoV) NTD than to the mouse hepatitis virus (MHV) NTD, with 3 of 4 critical sugar-binding residues in BCoV and 2 of 14 contact residues at the MHV NTD/murine CEACAM1a interface being conserved. Molecular clock analysis dated the time of the most recent common ancestor of ChRCoV HKU24, Betacoronavirus 1 , and rabbit coronavirus HKU14 to about the year 1400. Cross-reactivities between other lineage A and B βCoVs and ChRCoV HKU24 nucleocapsid but not spike polypeptide were demonstrated. Using the spike polypeptide-based Western blot assay, we showed that only Norway rats and two oriental house rats from Guangzhou, China, were infected by ChRCoV HKU24. Other rats, including Norway rats from Hong Kong, possessed antibodies only against N protein and not against the spike polypeptide, suggesting infection by βCoVs different from ChRCoV HKU24. ChRCoV HKU24 may represent the murine origin of Betacoronavirus 1 , and rodents are likely an important reservoir for ancestors of lineage A βCoVs. IMPORTANCE While bats and birds are hosts for ancestors of most coronaviruses (CoVs), lineage A βCoVs have never been found in these animals and the origin of Betacoronavirus lineage A remains obscure. We discovered a novel lineage A βCoV, China Rattus coronavirus HKU24 (ChRCoV HKU24), from Norway rats in China with a high seroprevalence. The unique genome features and phylogenetic analysis supported the suggestion that ChRCoV HKU24 represents a novel CoV species, occupying a deep branch at the root of members of Betacoronavirus 1 and being distinct from murine coronavirus. Nevertheless, ChRCoV HKU24 possessed genome characteristics that resemble those of both Betacoronavirus 1 and murine coronavirus. Our data suggest that ChRCoV HKU24 represents the murine origin of Betacoronavirus 1 , with interspecies transmission from rodents to other mammals having occurred centuries ago, before the emergence of human coronavirus (HCoV) OC43 in the late 1800s. Rodents are likely an important reservoir for ancestors of lineage A βCoVs.
    Betacoronavirus
    Coronavirus
    Bovine coronavirus
    Mouse hepatitis virus
    Coronaviridae
    Lineage (genetic)
    Citations (187)
    2019-20 coronavirus outbreak
    Coronavirus
    Betacoronavirus
    Coronavirus Infections
    Sars virus
    Pandemic
    Citations (0)
    The year of 2019–2021 is emergency that the world is facing due to the spread of 2019-nCoV which has created a very critical condition in human society, known as COVID-19. The complex virus belongs to the family of coronaviridae and genera betacoronavirus and spreads through human interaction. The common symptoms observed in infected are a sudden rise in body temperature within 1 st to 9 th day of infection, problems around the neck and throat from the start of the infection followed by the spread of infection into the lungs that cause novel coronavirus pneumonia and kidney failure. Many of the receptor proteins of the severe acute respiratory syndrome coronavirus (SARS-CoV-2) and target proteins of the human cells are responsible for endocytosis such as main protease or 3C-like protease, RNA polymerase, and spike protein. These proteins play a vital role in the life cycle of SARS-CoV-2. Many of the computational designed drugs and docking-based drugs are reported as anti-COVID-19. Many of the drugs show strong potent activity against this deadly virus. This study demonstrates the synthetic and computational designed approach, drugs, and compounds for the potential inhibition of the SARS-CoV-2 virus. The review will be helpful in finding a new approach of a drug as an inhibitory receptor of SARS-CoV-2.
    Coronavirus
    Coronaviridae
    Betacoronavirus
    Viral life cycle
    Citations (5)
    Design of hACE2-based small peptide inhibitors against spike protein of SARS-CoV-2: a computational approach,
    Coronavirus
    2019-20 coronavirus outbreak
    Betacoronavirus
    Coronavirus Infections
    Pandemic
    Sars virus
    Citations (147)
    2019-20 coronavirus outbreak
    Coronavirus
    Betacoronavirus
    Coronavirus Infections
    Pandemic
    Sars virus
    Citations (0)